Cargando…
Patient equity and respiratory syncytial virus Immunoprophylaxis
An analysis of benefit and cost is critical for independent advisory groups that provide evidence-based recommendations. In many countries, the role of RSV immunoprophylaxis for infants at increased risk of hospitalization is controversial because of limited benefit and high cost. The report by Gins...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348622/ https://www.ncbi.nlm.nih.gov/pubmed/30686271 http://dx.doi.org/10.1186/s13584-019-0288-6 |